Research News
View articles by month and year
1–5 of 5 articles
-
Chemo During Pregnancy Appears Safe for Mother and Child
A study supports other research that suggests chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Taxotere Better Than Fluorouracil in Chemo Regimen After Surgery for Early-Stage Disease
Chemotherapy that included Taxotere offered slightly better results than a regimen that included 5-FU for women diagnosed with early-stage breast cancer that hadn't spread to the lymph nodes, but Taxotere was more likely to cause serious side effects.
-
Adding Taxotere to Standard Chemo Doesn’t Seem to Help Treat Early-Stage Breast Cancer
Taxotere doesn't seem to offer any benefits in treating early-stage breast cancer and also causes more serious side effects.
-
Older Women Do Better on Conventional Chemo Compared to Xeloda
Research shows that women older than 65 do better on standard intravenous chemotherapy after surgery to remove early-stage breast cancer than Xeloda (chemical name: capecitabine), an oral chemotherapy.
-
Taxol Added to Chemo Combination Improved Survival of Women Diagnosed with Early-Stage Breast Cancer
After surgery to treat early-stage breast cancer, women who got Taxol after the FEC (fluorouracil, Ellence, Cytoxan) chemotherapy combination were more likely to be alive and cancer-free 5 years after diagnosis than women who got only FEC.
1–5 of 5 articles
